BiotechTube
Home/BioXyTran/David Platt
DP

David Platt

CEO & Chairman

BioXyTran

Therapeutic Areas

Infectious DiseaseCardiovascularNeurologyWound Care

BioXyTran Pipeline

DrugIndicationPhase
ProLectin (BXT-25)COVID-19 / SARS-CoV-2Phase 2
BXT-25Acute Respiratory Distress Syndrome (ARDS)Preclinical

Leadership Team at BioXyTran

OS
Ola Soderquist
CFO
LA
Leslie Ajayi
CMO & Medical Advisory Board Chief
View full BioXyTran profile